Gene · 667
Papers2,071
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,071
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Robust prognostic model based on immune infiltration-related genes and clinical information in ovarian cancer. | J Cell Mol Med | 2022 | 35735060 | PubTator, text mining | PubMed |
| Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia. | Front Oncol | 2022 | 35719952 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Intracranial Arteries in Adult Patients With Moyamoya Disease Reveals Novel Insights Into Its Pathogenesis. | Front Mol Neurosci | 2022 | 35711733 | PubTator, text mining | PubMed |
| Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia. | J Mol Cell Biol | 2022 | 35709398 | PubTator, text mining | PubMed |
| Mechanism of periplakin on ovarian cancer cell phenotype and its influence on prognosis. | Transl Cancer Res | 2022 | 35706781 | PubTator, text mining | PubMed |
| The power of heteronemin in cancers. | J Biomed Sci | 2022 | 35705962 | PubTator, text mining | PubMed |
| Post-translational modifications to hemidesmosomes in human airway epithelial cells following diacetyl exposure. | Sci Rep | 2022 | 35697719 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| A Rice R2R3-Type MYB Transcription Factor OsFLP Positively Regulates Drought Stress Response via OsNAC. | Int J Mol Sci | 2022 | 35682553 | PubTator, text mining | PubMed |
| New Onset Mitral Regurgitation Caused by Mitral Valve Prolapse in a Male Patient with Dominant Pretibial Dystrophic Epidermolysis Bullosa. | Indian J Dermatol | 2022 | 35656246 | PubTator, text mining | PubMed |
| Towards bridging the translational gap by improved modeling of human nociception in health and disease. | Pflugers Arch | 2022 | 35655042 | PubTator, text mining | PubMed |
| Developing a novel tool to assess the ability to self-administer medication in non-demented in-hospital patients: ABLYMED study protocol. | BMC Geriatr | 2022 | 35641903 | PubTator, text mining | PubMed |
| Bullous pemphigoid and milia: prevalence and clinical laboratory findings in a Brazilian sample. | An Bras Dermatol | 2022 | 35637051 | PubTator, text mining | PubMed |
| An ASIP for Neural Network Inference on Embedded Devices with 99% PE Utilization and 100% Memory Hidden under Low Silicon Cost. | Sensors (Basel) | 2022 | 35632250 | PubTator, text mining | PubMed |
| A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets. | J Clin Med | 2022 | 35628982 | PubTator, text mining | PubMed |
| Rapid Molecular Diagnosis of Genetically Inherited Neuromuscular Disorders Using Next-Generation Sequencing Technologies. | J Clin Med | 2022 | 35628876 | PubTator, text mining | PubMed |
| Ancient Origins of Cytoskeletal Crosstalk: Spectraplakin-like Proteins Precede the Emergence of Cortical Microtubule Stabilization Complexes as Crosslinkers. | Int J Mol Sci | 2022 | 35628404 | PubTator, text mining | PubMed |
| Prognostic implications of PPL expression in ovarian cancer. | Discov Oncol | 2022 | 35612641 | PubTator, text mining | PubMed |
| The molecular characteristics of gastric cancer patients living in Qinghai-Tibetan Plateau. | BMC Gastroenterol | 2022 | 35568828 | PubTator, text mining | PubMed |
| Genomic Profile in a Non-Seminoma Testicular Germ-Cell Tumor Cohort Reveals a Potential Biomarker of Sensitivity to Platinum-Based Therapy. | Cancers (Basel) | 2022 | 35565196 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/667/papers?page=17